唾液腺恶性肿瘤中的择区性颈淋巴结清扫:系统综述与Meta分析
该系统综述与Meta分析纳入51项研究共11698例临床淋巴结阴性唾液腺恶性肿瘤患者,评估隐匿性淋巴结转移率及择区性颈淋巴结清扫的作用。结果显示,唾液腺导管癌的隐匿性淋巴结转移率为64%,未分化癌为51%,多形性腺瘤癌变为34%,腺癌非特指型为32%,淋巴上皮癌为31%,黏液表皮样癌为20%,腺泡细胞癌和腺样囊性癌均为17%;T3/T4期肿瘤的隐匿性淋巴结转移风险是T1/T2期的2.3倍,高级别肿瘤是低/中级别肿瘤的3.8倍。
要点
- 临床淋巴结阴性唾液腺恶性肿瘤中,唾液腺导管癌的隐匿性淋巴结转移率最高(64%)。
- T3/T4期肿瘤的隐匿性淋巴结转移风险是T1/T2期的2.3倍。
- 高级别肿瘤的隐匿性淋巴结转移风险是低/中级别肿瘤的3.8倍。
核心结论
- T3/T4期、高级别、未分化癌、唾液腺导管癌、腺癌非特指型、多形性腺瘤癌变和淋巴上皮癌的隐匿性淋巴结转移率极高,提示择区性颈淋巴结清扫可能具有潜在作用。
研究设计与样本
- Meta分析检索4个数据库,检索时间从数据库建库至2020年3月25日。
- 共纳入51项研究、11698例患者。
主要发现
- 隐匿性淋巴结转移率:唾液腺导管癌64%,未分化癌51%,多形性腺瘤癌变34%,腺癌非特指型32%,淋巴上皮癌31%,黏液表皮样癌20%,腺泡细胞癌17%,腺样囊性癌17%。
- T3/T4期肿瘤的隐匿性淋巴结转移风险是T1/T2期肿瘤的2.3倍。
- 高级别肿瘤的隐匿性淋巴结转移风险是低/中级别肿瘤的3.8倍。
临床怎么用
- 原文结论指出,T3/T4期、高级别、未分化癌、唾液腺导管癌、腺癌非特指型、多形性腺瘤癌变和淋巴上皮癌的隐匿性淋巴结转移率极高,提示择区性颈淋巴结清扫可能具有潜在作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We defined the occult nodal metastasis (ONM) rate of clinical node-negative salivary gland malignancies and examined the role of elective neck dissection (END). Meta-analysis querying four databases, from inception of databases to March 25th, 2020. Fifty-one studies with 11 698 patients were included. ONM rates were 64% for salivary ductal carcinoma (SDC), 51% for undifferentiated carcinoma, 34% for carcinoma ex-pleomorphic adenoma (CXPA), 32% for adenocarcinoma not otherwise specified (ANOS), 31% for lymphoepithelial carcinoma (LE), 20% for mucoepidermoid carcinoma, 17% for acinic cell carcinoma, and 17% for adenoid cystic carcinoma. T3/T4 tumors had a 2.3 times increased risk of ONM than T1/T2 tumors. High-grade tumors had a 3.8 times increased risk of ONM than low/intermediate-grade tumors. ONM rates were exceedingly high for T3/T4, high-grade, and undifferentiated, SDC, ANOS, CXPA, and LE tumors, indicating the potential role of END.
引用
- Yan F, Lao WP, Nguyen SA, et al. Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis. Head Neck. 2021. PMID: 34862810. doi:10.1002/hed.26923
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。